-
Search
 
 
  
 Other POC-IT Resources
 

POC-IT Center
ABX Guide
HIV Guide

 Related Sites
 

PAHO
Medical Association of Trinidad
CHRC guidelines
Trinidad and Tobago Ministry of Health
CDAP - The Chronic Disease Assistance Programme

 Guide Editors
 Editor In Chief
    Christopher D. Saudek, M.D.

Managing Editor
    Rita Rastogi Kalyani, M.D., M.H.S.

Advisor
    Frederick L. Brancati, M.D., M.H.S.
 

Complications and Comorbidities> Ophthalmology/Otology>
Diabetes Guide Home PageEmail this module to a friend

Cataracts

Sachin Kalyani, M.D.
02-24-2010

DEFINITION

  • A clouding or opacity of the natural crystalline lens of the eye.
  • When glucose increases in the lens (as in hyperglycemic states), the sorbitol pathway is activated more than glycolysis; sorbitol accumulates and is retained in the lens.
  • Along with sorbitol, fructose also builds up in a lens surrounded by a high glucose environment.
  • These two sugars increase the osmotic pressure within the lens, drawing in water.
  • The result is swelling of the lens fibers, disruption of the normal cytoskeletal architecture, and ultimately, lens opacification (Andley).

EPIDEMIOLOGY

  • Persons with diabetes(DM)  are at increased risk of age-related lens changes indistinguishable from nondiabetic age-related cataracts.
  • The lens changes occur at a younger age than in people without DM (Flynn).
  • With DM, cortical or posterior subcapsular opacities also occur earlier than in age-matched controls.
  • Cataracts present in 20% of patients with type 1 DM, associated with age, history of retina photocoagulation, higher serum creatinine values and hypertension (Esteves).
  • The number of cataract cases among adults 40 years or older with DM will likely increase 235% by 2050 (Saaddine).

DIAGNOSIS

  • History evaluates if vision is affecting patient's activities of daily living (ADL) (e.g. driving, reading, watching TV).
  • Comprehensive eye exam, including visual acuity, slit lamp examination, and a dilated funduscopic examto evaluate the cataract.
  • On examination, funduscopic exam may reveal a clouding of the lens and difficult or hazy view of the retina.

SIGNS AND SYMPTOMS

  • Cloudy or blurry vision
  • Glare (headlights or sunlight may decrease vision); halos around lights
  • Poor night vision
  • Subdued colors
  • Monocular diplopia or multiple images in one eye

CLINICAL TREATMENT

  • Symptoms of early cataract may be improved with new eyeglasses, brighter lighting, anti-glare sunglasses, or magnifying lenses.
  • If the above measures are not adequate, surgery is only effective treatment, usually cataract extraction with phacoemulisification and intraocular lens implantation.
  • Cataract surgery usually recommended only when vision loss interferes with ADLs.
  • Other indication for cataract surgery: if the cataract prevents examination or treatment of another eye problem such as diabetic retinopathy or age-related macular degeneration
  • Diabetic retinopathy may progress following cataract surgery (Jaffe)
  • Therefore, consider laser photocoagulation prior to cataract surgery for patients with CSME, NPDR, or PDR

FOLLOW UP

  • Reevaluate all patients with preexisting diabetic retinopathy following cataract surgery.
  • Patients with DM undergoing phacoemulsification cataract surgery have a doubling of diabetic retinopathy progression 12 months after surgery (Hong).
  • This outcome, however, represents less progression than was previously documented with intracapsular and extracapsular cataract surgical techniques (Jaffe).
  •  

EXPERT COMMENTS

  • Cataracts usually present bilaterally, however, may have progressed more in one eye.
  • Best corrected visual acuity after cataract extraction may be limited secondary to diabetic retinopathy.

REFERENCES


 
 
Home
 
Overview
 
Management
 
Complications and Comorbidities
 
Medications
 
Clinical Tests
 
Trinidad and Tobago Specific Modules
 
View All Modules